LGND Ligand Pharmaceuticals PE ratio, current and historical analysis
As of Feb 21, 2025, the Ligand Pharmaceuticals stock's PE ratio is 45.71. This results from the current EPS of $2.64 and stock price of $120.67. The P/E ratio has an increase of 67% from the past four quarters average of 27.4.
LGND PE ratio history
The PE ratio of Ligand Pharmaceuticals has averaged 87.53 over the last ten years. The current PE ratio of 45.71 is 48% below the historical average. Over the past ten years, LGND's PE ratio was at its highest in the Sep 2020 quarter at 794.33, when the stock price was $95.32 and the EPS was $0.12. The lowest value was in the Dec 2019 quarter, when it reached 3.15 with a price of $104.29 and an EPS of $33.13.
Ligand Pharmaceuticals PE ratio by year
Maximum annual decrease: -91.22% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2023 | 23.65 | N/A | $71.42 | $3.02 |
| 2022 | N/A | N/A | $66.8 | -$1.98 |
| 2021 | 44.9 | N/A | $154.46 | $3.44 |
| 2020 | N/A | N/A | $99.45 | -$0.18 |
| 2019 | 3.15 | -84.28% | $104.29 | $33.13 |
| 2018 | 20.04 | -91.22% | $135.7 | $6.77 |
| 2017 | 228.22 | N/A | $136.93 | $0.6 |
| 2016 | N/A | N/A | $101.61 | -$0.08 |
| 2015 | 9.34 | -89.64% | $108.42 | $11.61 |
| 2014 | 90.19 | -3.98% | $53.21 | $0.59 |
| 2013 | 93.93 | N/A | $52.6 | $0.56 |
| 2012 | N/A | N/A | $20.74 | -$0.03 |
| 2011 | 24.22 | N/A | $11.87 | $0.49 |
| 2010 | N/A | N/A | $8.92 | -$0.53 |
| 2009 | N/A | N/A | $13.02 | -$0.1 |
Ligand Pharmaceuticals PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2024 | 37.91 | 9.79% | $100.09 | $2.64 |
| Jun 2024 | 34.53 | 157.49% | $84.26 | $2.44 |
| Mar 2024 | 13.41 | -43.3% | $73.1 | $5.45 |
| Dec 2023 | 23.65 | -62.11% | $71.42 | $3.02 |
| Sep 2023 | 62.42 | 35.93% | $59.92 | $0.96 |
| Jun 2023 | 45.92 | -13.23% | $72.1 | $1.57 |
| Mar 2023 | 52.92 | N/A | $73.56 | $1.39 |
| Dec 2022 | N/A | N/A | $66.8 | -$1.98 |
| Sep 2022 | N/A | N/A | $86.11 | -$1.27 |
| Jun 2022 | N/A | N/A | $89.22 | -$0.47 |
| Mar 2022 | 79.22 | 76.44% | $112.49 | $1.42 |
| Dec 2021 | 44.9 | 32.76% | $154.46 | $3.44 |
| Sep 2021 | 33.82 | -25.75% | $139.32 | $4.12 |
| Jun 2021 | 45.55 | -27.7% | $131.19 | $2.88 |
| Mar 2021 | 63 | N/A | $152.45 | $2.42 |
LGND average PE ratio chart
The current PE ratio of LGND is greater than its 3-year historical average, but it is below the 5 and 10-year averages.
LGND PE vs peers
LGND's PE ratio is lower than its peer stocks LLY and BAX, but it is greater than JNJ's and MRK's. Ligand Pharmaceuticals is presently trading at a higher PE ratio (45.71) than its peer group average of 39.03.
| Stock name | PE ratio | Market cap |
|---|---|---|
| MRK Merck & Co Inc | 18.68 | $226.4B |
| JNJ Johnson & Johnson | 27.79 | $390.76B |
| PFE Pfizer Inc | 34.61 | $149.04B |
| AMGN Amgen Inc | 39.77 | $162.78B |
| LGND Ligand Pharmaceuticals Inc | 45.71 | $2.28B |
| LLY ELI LILLY & Co | 74.29 | $828.4B |
| BMY Bristol Myers Squibb Co | N/A | $113.3B |
| BAX Baxter International Inc | N/A | $17.3B |
Frequently asked questions
What is Ligand Pharmaceuticals's PE ratio?
The price to earnings ratio for LGND stock is 45.71 as of Feb 21, 2025.
What is the 3-year average PE ratio for Ligand Pharmaceuticals (LGND)?
The 3-year average PE ratio for LGND stock is 43.75.
What is the 5-year average PE ratio for Ligand Pharmaceuticals (LGND)?
The 5-year average PE ratio for LGND stock is 102.43.
What is the highest PE ratio for LGND?
The highest quarterly PE ratio in the last ten years has been 794.33 and it was in the Sep 2020 quarter.
How does the current PE ratio for LGND compare to its historical average?
LGND's price to earnings ratio is currently 48% below its 10-year historical average.
How is LGND's PE ratio calculated (Ligand Pharmaceuticals PE ratio formula)?
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Feb 21, 2025), Ligand Pharmaceuticals's stock price is $120.67. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $2.64. Therefore, Ligand Pharmaceuticals's P/E ratio for today is 45.71. PE RATIO(45.71) = STOCK PRICE($120.67) / TTM EPS($2.64)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.